BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Drug Development

  Cell Therapeutics, Inc. Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial

  November 3, 2008

   · 

  5 min read
• Pharm Country

  Welch Allyn Recognized at 2008 HIDA MedSurg Conference and Expo

  November 3, 2008

   · 

  1 min read
• Business

  CuraGen Corporation Reports Third Quarter 2008 Financial Results

  November 3, 2008

   · 

  5 min read
• Business

  Mobile Imaging Innovator, Mobile Diagnostic Centers LP, Appoints New CEO

  November 3, 2008

   · 

  1 min read
• Deals

  Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific UK

  November 3, 2008

   · 

  3 min read
• Policy

  Genesis Pharmaceutical, Inc. Files Counter Claims

  November 3, 2008

   · 

  2 min read
• Business

  Amarin Corporation PLC Dr. Lars Ekman as Non-Executive Director

  November 3, 2008

   · 

  1 min read
• Drug Development

  Portola Pharmaceuticals, Inc. Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation

  November 3, 2008

   · 

  5 min read
• Drug Development

  Romark Laboratories, L.C. Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008

  November 3, 2008

   · 

  4 min read
• Drug Development

  CuraGen Corporation Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma

  November 3, 2008

   · 

  9 min read